132 related articles for article (PubMed ID: 8592170)
1. Neural cell adhesion molecule expression in human pituitary adenomas.
Kleinschmidt-DeMasters BK; Conway DR; Franklin WA; Lillehei KO; Kruse CA
J Neurooncol; 1995; 25(3):205-13. PubMed ID: 8592170
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.
Mendes GA; Haag T; Trott G; Rech CGSL; Ferreira NP; Oliveira MC; Kohek MB; Pereira-Lima JFS
Braz J Med Biol Res; 2017 Dec; 51(2):e6808. PubMed ID: 29267504
[TBL] [Abstract][Full Text] [Related]
3. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the neural cell adhesion molecule NCAM 140 in human pituitary tumors.
Aletsee-Ufrecht MC; Langley K; Gratzl O; Gratzl M
FEBS Lett; 1990 Oct; 272(1-2):45-9. PubMed ID: 2121537
[TBL] [Abstract][Full Text] [Related]
6. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
Shimon I; Hinton DR; Weiss MH; Melmed S
Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
[TBL] [Abstract][Full Text] [Related]
7. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas.
Jones TH; Figueroa CD; Smith CM; Cullen DR; Bhoola KD
J Endocrinol; 1992 Jul; 134(1):149-54. PubMed ID: 1500840
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenomas: immunohistochemical: study of 90 cases.
Kasantikul V; Shuangshoti S
J Med Assoc Thai; 1990 Sep; 73(9):514-21. PubMed ID: 2262756
[TBL] [Abstract][Full Text] [Related]
9. Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy.
Daniel L; Trouillas J; Renaud W; Chevallier P; Gouvernet J; Rougon G; Figarella-Branger D
Cancer Res; 2000 Jan; 60(1):80-5. PubMed ID: 10646857
[TBL] [Abstract][Full Text] [Related]
10. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas.
Talan-Hranilović J; Gnjidić Z; Sajko T; Vizner B; Vrkljan M
Acta Med Croatica; 2000; 54(2):59-63. PubMed ID: 11028110
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-containing pituitary adenomas. Their characteristics and comparative study with non-prolactin adenomas.
Ho DM; Liu HC
Pathol Res Pract; 1992 Apr; 188(3):296-302. PubMed ID: 1625993
[TBL] [Abstract][Full Text] [Related]
12. Gene and protein expression of E-cadherin and NCAM markers in non-functioning pituitary adenomas.
Ongaratti BR; Haag T; D'Ávila MF; Trott G; Ferreira NP; Rech CGSL; Pereira-Lima JFS; da Costa Oliveira M
Ann Diagn Pathol; 2019 Feb; 38():59-61. PubMed ID: 30419428
[TBL] [Abstract][Full Text] [Related]
13. Neural cell adhesion molecule (NCAM) in normal and neoplastic human pituitary tissues: Analysis by immunohistochemistry and in situ hybridization.
Jin L; Stone M; Chandler WF; Lloyd RV
Endocr Pathol; 1992 Sep; 3(3):144-151. PubMed ID: 32370452
[TBL] [Abstract][Full Text] [Related]
14. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
15. Expression and secretion of neural cell adhesion molecules by human pituitary adenomas.
De Jong I; Aylwin SJ; Olabiran Y; Geddes JF; Monson JP; Wood DF; Burrin JM
Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():660-5. PubMed ID: 10505219
[TBL] [Abstract][Full Text] [Related]
16. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
17. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.
Tsagarakis S; Kontogeorgos G; Giannou P; Thalassinos N; Woolley J; Besser GM; Grossman A
Clin Endocrinol (Oxf); 1992 Aug; 37(2):163-7. PubMed ID: 1327588
[TBL] [Abstract][Full Text] [Related]
19. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
